ArticleACS pharmacology & translational science2026

Protease-Activated Receptor 4 (PAR4)-Tethered Ligand Antagonists Demonstrate Thrombin Liability.

Emma M Webb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.